Featured Article

The Implementation and First‐Round Results of a Community‐Based Colorectal Cancer Screening Program in Shanghai, China
Yangming Gong, Peng Peng, Pingping Bao, Weijian Zhong, Yan Shi, Kai Gu, Ying Zheng, Chunxiao Wu, Sanjun Cai, Ye Xu, Jun Sheng and Fan Wu
The Oncologist 2018; first published on March 14, 2018; doi: 10.1634/theoncologist.2017-0451

Recent Translated Articles from The Oncologist

Volume 23: Number 5, May 2018

Clinical Trial Results

在新诊断出恶性胶质瘤且体能状态欠佳的老年患者中进行替莫唑胺+贝伐单抗治疗:一项ANOCEF II期试验(ATAG)
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)
Germán Reyes‐Botero, Stéphanie Cartalat‐Carel, Olivier L. Chinot, Maryline Barrie, Luc Taillandier, Patrick Beauchesne, Isabelle Catry‐Thomas, Jérôme Barrière, Jean‐Sebastien Guillamo, Michel Fabbro, Didier Frappaz, Alexandra Benouaich‐Amiel, Emilie Le Rhun, Chantal Campello, Isabelle Tennevet, François Ghiringhelli, Marie‐Laure Tanguy, Karima Mokhtari, Jérôme Honnorat, Jean‐Yves Delattre
The Oncologist 2018; 23:524-e44; first published on February 22, 2018; doi:10.1634/theoncologist.2017-0689

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas
William N. William Jr., Anne S. Tsao, Lei Feng, Lawrence E. Ginsberg, J. Jack Lee, Merrill S. Kies, Bonnie S. Glisson, Edward S. Kim
The Oncologist 2018; 23:526-e49; first published on January 25, 2018; doi:10.1634/theoncologist.2017-0661

Academia-Pharma Intersect: Breast Cancer

Estrogen Receptor‐Positive Breast Cancer: Exploiting Signaling Pathways Implicated in Endocrine Resistance
Adam M. Brufsky, Maura N. Dickler
The Oncologist 2018; 23:528-539; first published on January 19, 2018; doi:10.1634/theoncologist.2017-0423

Breast Cancer

Luminal A型乳腺癌和分子检测:综述
Luminal A Breast Cancer and Molecular Assays: A Review
Jennifer J. Gao, Sandra M. Swain
The Oncologist 2018; 23:556-565; first published on February 22, 2018; doi:10.1634/theoncologist.2017-0535


Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
Sadakatsu Ikeda, Igor F. Tsigelny, Åge A. Skjevik, Yuko Kono, Michel Mendler, Alexander Kuo, Jason K. Sicklick, Gregory Heestand, Kimberly C. Banks, AmirAli Talasaz, Richard B. Lanman, Scott Lippman, Razelle Kurzrock
The Oncologist 2018; 23:586-593; first published on February 27, 2018; doi:10.1634/theoncologist.2017-0479

Symptom Management and Supportive Care

含奥氮平的三联方案与含神经激肽-1 受体拮抗剂的三联方案在预防与高致吐性化疗相关的化疗所致恶心呕吐方面的比较:网络荟萃分析
Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis
Zhonghan Zhang, Yaxiong Zhang, Gang Chen, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Fan Luo, Xi Chen, Yuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Cong Xue, Xue Hou, Ting Zhou, Shuxiang Ma, Fangfang Gao, Yan Huang, Likun Chen, Ningning Zhou, Hongyun Zhao, Li Zhang
The Oncologist 2018; 23:603-616; first published on January 12, 2018; doi:10.1634/theoncologist.2017-0378